Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ICPT | AMGN | BMY | GILD | VRTX |
| Company | Intercept Pharmaceuticals | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 19.00 | 269.84 | 49.00 | 66.93 | 397.30 |
| High | 19.01 | 273.14 | 49.56 | 67.57 | 406.34 |
| Low | 18.98 | 269.84 | 48.87 | 66.74 | 396.00 |
| Last | 19.00 | 271.91 | 49.14 | 66.95 | 399.92 |
| Change | +0.04 | +2.98 | +0.21 | +0.19 | +5.64 |
| % Change | +0.21% | +1.11% | +0.43% | +0.28% | +1.43% |
| Volume | 3,963,400 | 2,165,700 | 7,929,500 | 5,622,300 | 1,393,800 |
| 20-Day Average Volume | 1,984,495 | 2,239,560 | 11,113,590 | 6,350,505 | 960,430 |
| Previous Close | 18.96 | 268.93 | 48.93 | 66.76 | 394.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.81 | 272.35 | 50.71 | 69.61 | 404.73 |
| 20-Day Raw Stochastic | 99.00% | 40.27% | 22.23% | 13.17% | 29.27% |
| 20-Day Relative Strength | 74.51% | 47.06% | 42.35% | 32.36% | 43.46% |
| Weighted Alpha | -13.30 | +10.54 | -25.43 | -20.99 | +15.75 |
| Today's Opinion | 88% Buy | 40% Sell | 88% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 88% Buy | 56% Sell | 72% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 56% Buy | 8% Buy | 24% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.37% since 10/31/23 | +2.41% since 04/15/24 | +1.30% since 04/15/24 | -1.18% since 04/15/24 | +0.64% since 04/15/24 |
| Low | 18.93 on 11/02/23 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 19.02 on 11/06/23 | 273.14 on 04/22/24 | 49.56 on 04/22/24 | 67.89 on 04/16/24 | 406.34 on 04/22/24 |
| 1-Month | |||||
| %Chg | +2.15% since 10/06/23 | -1.54% since 03/22/24 | -5.37% since 03/22/24 | -7.80% since 03/22/24 | -3.79% since 03/22/24 |
| Low | 17.01 on 10/13/23 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 19.02 on 11/06/23 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +82.87% since 08/07/23 | -12.33% since 01/22/24 | -0.87% since 01/22/24 | -14.64% since 01/22/24 | -9.13% since 01/22/24 |
| Low | 9.70 on 08/14/23 | 260.68 on 04/19/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 19.02 on 11/06/23 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +17.57% since 05/05/23 | -2.47% since 10/20/23 | -12.96% since 10/20/23 | -13.95% since 10/20/23 | +10.52% since 10/20/23 |
| Low | 8.82 on 05/24/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 19.02 on 11/06/23 | 329.72 on 02/05/24 | 56.77 on 10/25/23 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 793,877 | 144,247,584 | 99,169,320 | 83,121,344 | 101,905,216 |
| Shares Outstanding, K | 41,783 | 536,376 | 2,026,759 | 1,245,077 | 258,459 |
| Annual Sales | 285,710,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 221,820,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 83,720,000 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -5,860,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 0.88 | 0.58 | 0.39 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 11/06/23 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 11/07/23 | 05/02/24 | 04/25/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.09 | 6.44 | 9.85 | 29.28 |